Home » Topics » Regulatory » EMA

EMA
RSS

Nivolumab receives EMA recommendation for squamous NSCLC

May 25, 2015

Imbruvica recommended for European approval in Waldenstrom's macroglobulinemia

May 25, 2015

Kuvan gets positive opinion from CHMP for expanded indication

May 25, 2015

Stelara recommended for European approval for plaque psoriasis in adolescents

May 25, 2015

EMA's CHMP supports approval of Repatha for high cholesterol

May 25, 2015

EMA committee hands down positive opinion for Keytruda in advanced melanoma

May 25, 2015

EMA committee recommends approval of Omidria

May 25, 2015

Isarna Therapeutics' ISTH-0036 receives E.U. orphan drug designation

May 22, 2015

Pluristem's PLX program selected for EMA's Adaptive Pathways pilot project

May 19, 2015

EMA committee recommends approval of new Orfadin formulations

May 8, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...